Introduction
Many studies over the past decade have implicated the overexpression of oncogenic transcription factors, including TAL1/SCL, HOX11, and LMO2 via chromosomal rearrangements, in the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL). 1 However, HOX11, TAL1 and LMO2 are frequently overexpressed in T-ALL samples in the absence of detectable cytogenetic abnormalities involving the chromosomal regions that contain these genes. 2, 3 These observations, coupled with the demonstration of biallelic expression of TAL1 and hypomethylation of HOX11 promoter sequences in T-ALL cases, support the hypothesis that mechanisms other than cis-acting chromosomal rearrangements can contribute to the aberrant expression of transcription factor oncogenes in T-ALL.
4,5
Here we report that the T-cell ALL oncogenes TAL1, HOX11 and LMO2 are biallelically expressed in a significant fraction of primary human T-ALL samples and propose a model for the pathogenesis of T-ALL involving the disruption of transcriptional pathways, which normally maintain tight control over the expression of these transcription factors during thymocyte development. 
Study design

Real-time quantitative RT-PCR
Real-time quantitative RT-PCR analysis of HOX11, TAL1, LMO2 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was performed as previously described. 
T-cell progenitor FACS cell sorting and RT-PCR.
Single cell suspensions from surgically removed mouse thymi were stained with conjugated antibodies against CD4, CD8, TCR , CD44, CD25 and Thy1.2.
Immunofluorescence analysis was performed on the Moflo flow cytometer (Cytomation, Denver, CO) and 20,000 cells were collected according to their surface markers. RNA extraction, cDNA synthesis and RT-PCR amplification were performed as previously described. 6 Primer sequences used for RT-PCR of T-ALL oncogenes and the S16 control gene are available as supplemental material.
Results and Discussion
Allelic expression analysis of T -ALL oncogenes
Allele-specific analysis of TAL1 mRNA was performed in 29 T-ALL cases showing aberrant expression of this oncogene (Fig.1) . 10 Semi-quantitative RT-PCR was performed using specific primers for Tal1, Tal2, Lyl1, Bhlhb1, Lmo2, Lmo1, Hox11, Hox11l2, and S16 as control for the amounts of cDNA. PCR products were transferred to membranes and hybridized with internal oligonucleotide probes. cDNA prepared from E11.5 or E13.5 embryonic heads or total bone marrow (Lmo2) were used as positive controls for PCR amplification (CTL).
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